Email this article Hydroxyethyldimethyldihydropyrimidine as the drug of choice for the prevention of paraprosthetic seromas in breast reconstructive surgery: A retrospective study
- Authors: Khodyrev S.A.1, Shabaev R.M.2, Kolyadina I.V.3,4, Starokon P.M.1, Levchuk A.L.2, Samoylenko V.M.5
-
Affiliations:
- Kirov Military Medical Academy
- Pirogov Russian National Research Medical University
- Russian Medical Academy of Continuous Professional
- EducationKulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
- Sechenov First Moscow State Medical University (Sechenov University)
- Issue: Vol 25, No 2 (2023)
- Pages: 214-220
- Section: CLINICAL ONCOLOGY
- URL: https://journal-vniispk.ru/1815-1434/article/view/132820
- DOI: https://doi.org/10.26442/18151434.2023.2.202305
- ID: 132820
Cite item
Full Text
Abstract
Background. The most common complication in breast reconstructive surgery using silicone implants after radical treatment for neoplasms is long-lasting lymphorrhea after the resection stage, which threatens the development of postoperative complications. The improvement of the surgical technique of reconstructive and reconstructive operations on the mammary gland does not allow to exclude tissue injury with the formation of a cavity, into which foreign materials (mesh endoprosthesis, silicone implant) are subsequently installed, which are one of the main factors in the formation of seroma. Optimization of pharmacotherapy support in the early postoperative period allows to minimize the manifestations of lymphorrhea and serogenesis, to improve the quality of life of patients.
Materials and methods. A retrospective analysis of the treatment of 75 patients who underwent reconstructive breast surgery in the combined and complex treatment of breast cancer was carried out. The patients were divided into two representative groups depending on the intake of hydroxyethyldimethyldihydropyrimidine, a pyrimidine-type drug. At the same time, in one of the groups, hydroxyethyldimethyldihydropyrimidine was prescribed in accordance with the instructions for the use of this drug in order to optimize the wound process and prevent purulent-inflammatory disorders in the early postoperative period.
Results. In group 1 patients taking hydroxyethyldimethyldihydropyrimidine, there was a decrease in the duration of lymphorrhea by 2 times from 5.4 days (group 2) to 2.6 days after surgery. In addition, no cases of paraprosthetic seroma formation were recorded in group 1, while puncture management of paraprosthetic lymphocele was performed in 16 patients of group 2.
Conclusion. The inclusion of hydroxyethyldimethyldihydropyrimidine in the pharmacotherapy of maintenance in the early postoperative period in the study group of patients made it possible to significantly reduce the duration and volume of lymphorrhea, remove trapping drains from the paraprosthetic space earlier, prevent the formation of paraprosthetic seroma and the development of other, more formidable complications (suppuration, capsular contracture, silicone implant extrusion).
Full Text
##article.viewOnOriginalSite##About the authors
Sergey A. Khodyrev
Kirov Military Medical Academy
Email: kampramis@mail.ru
Res. Officer
Russian Federation, MoscowRamis M. Shabaev
Pirogov Russian National Research Medical University
Author for correspondence.
Email: kampramis@mail.ru
ORCID iD: 0000-0002-0428-7454
SPIN-code: 6445-0472
Cand. Sci. (Med.)
Russian Federation, MoscowIrina V. Kolyadina
Russian Medical Academy of Continuous Professional; EducationKulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
Email: kampramis@mail.ru
ORCID iD: 0000-0002-1124-6802
D. Sci. (Med.)n Medical Academy of Continuous Professional Education, Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
Russian Federation, Moscow; MoscowPavel M. Starokon
Kirov Military Medical Academy
Email: kampramis@mail.ru
D. Sci. (Med.), Prof.
Russian Federation, MoscowAleksandr L. Levchuk
Pirogov Russian National Research Medical University
Email: kampramis@mail.ru
ORCID iD: 0000-0002-2904-0730
SPIN-code: 3600-2394
D. Sci. (Med.), Prof.
Russian Federation, MoscowVyacheslav M. Samoylenko
Sechenov First Moscow State Medical University (Sechenov University)
Email: kampramis@mail.ru
D. Sci. (Med.), Prof.
Russian Federation, MoscowReferences
- Van Bemmel AJ, Van de Velde CJ, Schmitz RF, Liefers GJ. Prevention of seroma formation after axillary dissection in breast cancer: a systematic review. Eur J Surg Oncol. 2011;37(10):829-35. doi: 10.1016/j.ejso.2011.04.012
- Лукоянычев Е.Е., Измайлов С.Г., Евсюков Д.А., и др. Фармакологи- ческая регуляция реакции воспаления при имплантации сетчатого протеза в лечении пациентов с наружными грыжами живота (экспериментально-клиническое исследование). Вестник экспериментальной и клинической хирургии. 2022;15(2):122-31 [Lukoianychev EE, Izmailov SG, Evsiukov DA, et al. Farmakologicheskaia reguliatsiia reaktsii vospaleniia pri implantatsii setchatogo proteza v lechenii patsientov s naruzhnymi gryzhami zhivota (eksperimental'no-klinicheskoe issledovanie). Vestnik eksperimental'noi i klinicheskoi khirurgii. 2022;15(2):122-31 (in Russian)]. doi: 10.18499/2070-478X-2022-15-2-122-130
- Измайлов С.Г., Измайлов Г.А., Аверьянов М.Ю., Резник В.С. Ксимедон в клинической практике. Нижний Новгород, 2001 [Izmailov SG, Izmailov GA, Aver'ianov MIu, Reznik VS. Ksimedon v klinicheskoi praktike. Nizhnii Novgorod, 2001 (in Russian)].
- Измайлов С.Г., Лукоянычев Е.Е., Леонтьев А.Е., и др. Профилакти- ческое применение Ксимедона в абдоминальной хирургии. Вестник экспериментальной и клинической хирургии. 2021;XIV(2):152-60 [Izmailov SG, Lukoianychev EE, Leont'ev AE, et al. Profilakticheskoe primenenie Ksimedona v abdominal'noi khirurgii. Vestnik eksperimental'noi i klinicheskoi khirurgii. 2021;XIV(2):152-60 (in Russian)]. doi: 10.18499/2070-478X-2021-14-2-152-160
- Погорельцев В.И., Валимухаметова Д.А. Изучение фармакокинетики ксимедона в крови. Материалы респ. науч.-практ. конф., Нижнекамск. Казань, 1994; с. 80-1 [Pogorel'tsev VI, Valimukhametova DA. Izuchenie farmakokinetiki ksimedona v krovi. Materialy resp. nauch.-prakt. konf., Nizhnekamsk. Kazan', 1994; p. 80-1 (in Russian)].
- Измайлов С.Г., Паршиков В.В. Ксимедон: настоящее и будущее. Нижегородский медицинский журнал. 2002;3:81-7 [Izmailov SG, Parshikov VV. Ksimedon: nastoiashchee i budushchee. Nizhegorodskii meditsinskii zhurnal. 2002;3:81-7 (in Russian)].
- Паршиков В.В., Миронов А.А., Аникина Е.А., и др. Протезирующая пластика ультралегкими сетками в условиях бактериальной контаминации. Современные технологии в медицине. 2015;7(4):64-71 [Parshikov VV, Mironov AA, Anikina EA, et al. Proteziruiushchaia plastika ul'tralegkimi setkami v usloviiakh bakterial'noi kontaminatsii. Sovremennye tekhnologii v meditsine. 2015;7(4):64-71 (in Russian)]. doi: 10.17691/stm2015.7.4.08
- Иванов С.В., Иванов И.С., Мамедов Р.А., и др. Динамика профиля цитокинов у больных с послеоперационными грыжами брюшной стенки при протезировании с использованием политетрафторэтилена и поливинилиденфторида. Клиническая хирургия. 2012;7:37-41 [Ivanov SV, Ivanov IS, Mamedov RA, et al. Dinamika profilia tsitokinov u bol'nykh s posleoperatsionnymi gryzhami briushnoi stenki pri protezirovanii s ispol'zovaniem politetraftoretilena i polivinilidenftorida. Klinicheskaia khirurgiia. 2012;7:37-41 (in Russian)]. PMID: 23033777.
- Kokotovic D, Burcharth J, Helgstrand F, Gögenur I. Systemic inflammatory response after hernia repair: a systematic review. Langenbecks Arch Surg. 2017;402(7):1023-37. doi: 10.1007/s00423-017-1618-1
- Доброквашин С.В., Измайлов А.Г., Шакирова Д.Х., Василькин Д.А. Применение препарата Ксимедон в хирургической практике. Практические рекомендации. Казань: Татхимфармпрепараты, 2017 [Dobrokvashin SV, Izmailov AG, Shakirova DKh, Vasil'kin DA. Primenenie preparata Ksimedon v khirurgicheskoi praktike. Prakticheskie rekomendatsii. Kazan': Tatkhimfarmpreparaty, 2017 (in Russian)].
- Измайлова А.Х., Шакирова Д.Х., Измайлов А.Г. Препараты пиримидинового ряда в экспериментальных и клинических исследованиях. Вестник современной клинической медицины. 2013;6(прил. 2):31-4 [Izmailova AKh, Shakirova DKh, Izmailov AG. Preparaty pirimidinovogo riada v eksperimental'nykh i klinicheskikh issledovaniiakh. Vestnik sovremennoi klinicheskoi meditsiny. 2013;6(suppl. 2):31-4 (in Russian)].
- Измайлов А.Г. Производные пиримидинового ряда в хирургической практике. Современная медицина. 2018;2:177-82 [Izmailov AG. Proizvodnye pirimidinovogo riada v khirurgicheskoi praktike. Sovremennaia meditsina. 2018;2:177-82 (in Russian)].
- Измайлов С.Г., Леонтьев А.Е., Бесчастнов В.В., и др. Технические аспекты активного хирургического лечения проблемных ран мягких тканей. Нижний Новгород, 2020 [Izmailov SG, Leont'ev AE, Beschastnov VV, et al. Tekhnicheskie aspekty aktivnogo khirurgicheskogo lecheniia problemnykh ran miagkikh tkanei. Nizhnii Novgorod, 2020 (in Russian)].
- Ware JE Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473-83. PMID: 1593914.
Supplementary files
